Template:Oral potencies of estrogens

v
t
e
Potencies of oral estrogens^{[data sources 1]}
Compound	Dosage for specific uses (mg usually)^[a]
Compound	ETD^[b]	EPD^[b]	MSD^[b]	MSD^[c]	OID^[c]	TSD^[c]
Estradiol (non-micronized)	30	≥120–300	120	6	-	-
Estradiol (micronized)	6–12	60–80	14–42	1–2	>5	>8
Estradiol valerate	6–12	60–80	14–42	1–2	-	>8
Estradiol benzoate	-	60–140	-	-	-	-
Estriol	≥20	120–150^[d]	28–126	1–6	>5	-
Estriol succinate	-	140–150^[d]	28–126	2–6	-	-
Estrone sulfate	12	60	42	2	-	-
Conjugated estrogens	5–12	60–80	8.4–25	0.625–1.25	>3.75	7.5
Ethinylestradiol	200 μg	1–2	280 μg	20–40 μg	100 μg	100 μg
Mestranol	300 μg	1.5–3.0	300–600 μg	25–30 μg	>80 μg	-
Quinestrol	300 μg	2–4	500 μg	25–50 μg	-	-
Methylestradiol	-	2	-	-	-	-
Diethylstilbestrol	2.5	20–30	11	0.5–2.0	>5	3
DES dipropionate	-	15–30	-	-	-	-
Dienestrol	5	30–40	42	0.5–4.0	-	-
Dienestrol diacetate	3–5	30–60	-	-	-	-
Hexestrol	-	70–110	-	-	-	-
Chlorotrianisene	-	>100	-	-	>48	-
Methallenestril	-	400	-	-	-	-
Sources and footnotes: ^ ^[1]^[2]^[3]^[4]^[5]^[6] ^[7]^[8]^[9]^[10] ^[11]^[12]^[13]^[14]^[15]^[16]^[17]^[18]^[19] ^ Dosages are given in milligrams unless otherwise noted. ^ ^a ^b ^c Dosed every 2 to 3 weeks ^ ^a ^b ^c Dosed daily ^ ^a ^b In divided doses, 3x/day; irregular and atypical proliferation.

Usage